February 2022 Editor’s Choice: HRD: What does it really mean and are we looking at this the right way?
Listen now
Description
Hosted by:
Warner K. Huh, MD, FACOG, FACS, Deputy Editor of Gynecologic Oncology
Featuring:
Elizabeth Swisher, MD, UW Medicine
Jonathan A Ledermann, MD FRCP FMedSci Professor of Medical Oncology, UCL Cancer Institute
Editor’s Choice Paper: Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 study
Editorial: Testing for homologous recombination deficiency – does it provide new insights for the use of veliparib?
More Episodes
Editor’s Choice Paper:
Identifying safe diagnostic algorithms for sentinel lymph node mapping in high-risk endometrial cancer: The SENTIREC-endo study
Editorial:
Sentinel lymph node biopsy in high-risk endometrial cancer: The dénouement
Hosted by:
Gregg Nelson, MD, Social Media Editor...
Published 04/15/24
Published 04/15/24
Editor’s Choice Paper:
Experiences of patients with peritoneal carcinomatosis-related complex care needs and their caregivers
Editorial:
The importance of family-focused care in the setting of advanced gynecological cancers
Hosted by:
Sean Dowdy, MD, Associate Editor of Gynecologic...
Published 04/04/24
Links
Twitter
Facebook
Instagram
Patreon
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
